SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-082609
Filing Date
2021-06-17
Accepted
2021-06-17 16:13:17
Documents
14
Period of Report
2021-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119939d1_8k.htm   iXBRL 8-K 44115
2 EXHIBIT 10.1 tm2119939d1_ex10-1.htm EX-10.1 147957
3 EXHIBIT 10.2 tm2119939d1_ex10-2.htm EX-10.2 20733
  Complete submission text file 0001104659-21-082609.txt   422218

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imgn-20210616.xsd EX-101.SCH 3190
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20210616_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20210616_pre.xml EX-101.PRE 22713
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2119939d1_8k_htm.xml XML 3468
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 211024866
SIC: 2834 Pharmaceutical Preparations